Betamethadol
Systematic (IUPAC) name | |
---|---|
(3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanol | |
Clinical data | |
| |
Identifiers | |
17199-55-2 | |
None | |
PubChem | CID 10064061 |
ChemSpider | 8239601 |
ChEMBL | CHEMBL162243 |
Chemical data | |
Formula | C21H29NO |
311.461 g/mol | |
SMILES
| |
|
Betamethadol (INN), or β-methadol, also known as betametadol, is a synthetic opioid analgesic.[1] It is an isomer of dimepheptanol (methadol), the other being alphamethadol (α-methadol).[2] Betamethadol is composed of two isomers itself, L-β-methadol, and D-β-methadol.[2] Based on structure-activity relationships it can be inferred that both isomers are likely to be active as opioid analgesics, similarly to those of betacetylmethadol (β-acetylmethadol).[3]
Betamethadol is a Schedule I controlled substance in the United States and has a DEA ACSCN of 9609 and an annual aggregate manufacturing quota of 2 grammes.
See also
References
- ↑ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1294. ISBN 978-0-412-46630-4. Retrieved 15 May 2012.
- ↑ 2.0 2.1 United Nations Office on Drugs and Crime (2006). Dictionnaire Multilingue Des Stupéfiants Et Des Substances Psychotropes Placés Sous Contrôle International. United Nations Publications. p. 103. ISBN 978-92-1-048117-5. Retrieved 15 May 2012.
- ↑ Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.
|